The use of low-dose cyclosporine A in combination with azathioprine and steroids in renal transplantation.
D000328:Adult; D001379:Azathioprine / Q000008:administration & dosage* / Q000009:adverse effects; D001855:Bone Marrow Diseases / Q000139:chemically induced; D002102:Cadaver; D003524:Cyclosporins / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004357:Drug Synergism; D006084:Graft Rejection; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007165:Immunosuppression Therapy / Q000191:economics / Q000379:methods; D007674:Kidney Diseases / Q000139:chemically induced; D016030:Kidney Transplantation; D008775:Methylprednisolone / Q000008:administration & dosage* / Q000009:adverse effects; D011239:Prednisolone / Q000008:administration & dosage* / Q000009:adverse effects; D014019:Tissue Donors
D003524:Cyclosporins; D011239:Prednisolone; D001379:Azathioprine; D008775:Methylprednisolone